• Українською
  • In Ukraine, neonatal screening centers will be established to diagnose rare diseases in newborns
    Communications Department of the Secretariat of the CMU, posted 18 August 2021 14:06

    At the initiative of President Volodymyr Zelenskyy, the Government decided to establish neonatal screening centers in Ukraine. This was stated by Prime Minister Denys Shmyhal during a Government session on August 18.

    The Head of Government noted that such centers will conduct research that will allow timely detection of hereditary or congenital diseases in newborns. A UAH 300 million resource will be allocated from the budget for the creation of appropriate centers in 2021.

    "All newborns will have an opportunity to undergo appropriate examinations allowing to diagnose more than 20 different orphan diseases. The relevant program was initiated by the President to protect the lives of every small citizen of our country," the Prime Minister stressed.

    Moreover, Denys Shmyhal noted that the Government prolongs the transformation of the medical system and creates a biocluster "Biosafety and development of biotechnologies." The appropriate cluster will enable the launch of producing test systems for the diagnosis of infectious diseases, as well as vaccines.

    "In recent years and decades, Ukraine has almost completely lost the entire base for the production of vaccines and test systems for the diagnosis of infectious diseases. In order to fulfill the President's commisson, we started to change this situation last year. We are currently allocating UAH 100 million to create a cluster. This will allow combining public and private resources to maximize the educational, scientific and technical potential that we have in the country," stressed the Prime Minister.

     

    In Ukraine, neonatal screening centers will be established to diagnose rare diseases in newborns In Ukraine, neonatal screening centers will be established to diagnose rare diseases in newborns In Ukraine, neonatal screening centers will be established to diagnose rare diseases in newborns